Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2018| March-April  | Volume 20 | Issue 2  
    Online since March 1, 2018

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
Randomized controlled trials – mechanistic studies of testosterone and the cardiovascular system
T Hugh Jones, Daniel M Kelly
March-April 2018, 20(2):120-130
DOI:10.4103/aja.aja_6_18  PMID:29442075
  8,516 1,328 31
Trials of testosterone replacement reporting cardiovascular adverse events
Thiago Gagliano-Jucá, Shehzad Basaria
March-April 2018, 20(2):131-137
DOI:10.4103/aja.aja_28_17  PMID:28782738
  8,010 486 2
Testosterone treatment and cardiovascular events in prescription database studies
Molly M Shores
March-April 2018, 20(2):138-144
DOI:10.4103/aja.aja_25_17  PMID:28816202
  4,868 584 6
Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men
Bu B Yeap
March-April 2018, 20(2):109-114
DOI:10.4103/aja.aja_50_17  PMID:29199649
  4,423 721 8
Would male hormonal contraceptives affect cardiovascular risk?
Michael Zitzmann
March-April 2018, 20(2):145-148
DOI:10.4103/aja.aja_2_18  PMID:29384141
  4,574 550 2
Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion
Yao-An Wen, Bo-Wei Zhou, Dao-Jun Lv, Fang-Peng Shu, Xian-Lu Song, Bin Huang, Chong Wang, Shan-Chao Zhao
March-April 2018, 20(2):178-183
DOI:10.4103/aja.aja_57_17  PMID:29271400
  4,611 488 12
A retrospective review of single-institution outcomes with robotic-assisted microsurgical varicocelectomy
Andrew McCullough, Leon Elebyjian, Joseph Ellen, Clay Mechlin
March-April 2018, 20(2):189-194
DOI:10.4103/aja.aja_45_17  PMID:29086759
  4,409 530 10
Endogenous testosterone and mortality risk
Emily J Meyer, Gary Wittert
March-April 2018, 20(2):115-119
DOI:10.4103/aja.aja_70_17  PMID:29384142
  4,204 637 4
PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: evidence from patients in Northwestern China
Kai-Jie Wu, Xin-Qi Pei, Ge Tian, Da-Peng Wu, Jin-Hai Fan, Yu-Mei Jiang, Da-Lin He
March-April 2018, 20(2):173-177
DOI:10.4103/aja.aja_34_17  PMID:28905815
  4,178 513 4
External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer
Yun-Jie Yang, Guo-Wen Lin, Gao-Xiang Li, Bo Dai, Ding-Wei Ye, Jun-Long Wu, Hu-Yang Xie, Yao Zhu
March-April 2018, 20(2):184-188
DOI:10.4103/aja.aja_39_17  PMID:29111539
  3,977 506 4
Andrographolide sensitizes prostate cancer cells to TRAIL-induced apoptosis
Ruo-Jing Wei, Xin-Shi Zhang, Da-Lin He
March-April 2018, 20(2):200-204
DOI:10.4103/aja.aja_30_17  PMID:28869219
  3,961 503 16
An in vitro prototype of a porcine biomimetic testis-like cell culture system: a novel tool for the study of reassembled Sertoli and Leydig cells
Iva Arato, Giovanni Luca, Francesca Mancuso, Catia Bellucci, Cinzia Lilli, Mario Calvitti, Barbara C Hansen, Domenico Milardi, Giuseppe Grande, Riccardo Calafiore
March-April 2018, 20(2):160-165
DOI:10.4103/aja.ja_47_17  PMID:29148520
  3,927 482 12
Diagnosis of a Chinese man with 45,X/46,X,i(Y)(q10)/47,X,i(Y) (q10) ×2 mosaic Turner syndrome
Yan-Wei Sha, Lu Ding, Zhi-Yong Ji, Yun-Sheng Ge, Hui Kong, Qing Zhang, Yu-Lin Zhou, Ping Li
March-April 2018, 20(2):205-207
DOI:10.4103/1008-682X.193162  PMID:28091398
  4,024 371 -
Lipoxin A4 improves erectile dysfunction in rats with type I diabetes by inhibiting oxidative stress and corporal fibrosis
Kai Cui, Zhe Tang, Chuan-Chang Li, Tao Wang, Ke Rao, Shao-Gang Wang, Ji-Hong Liu, Zhong Chen
March-April 2018, 20(2):166-172
DOI:10.4103/aja.aja_49_17  PMID:29111541
  3,725 457 16
Why is understanding the relationship of testosterone to cardiovascular risk so important?
Bu B Yeap, Bradley D Anawalt
March-April 2018, 20(2):107-108
DOI:10.4103/aja.aja_71_17  PMID:29405170
  3,557 587 1
The expression of the new epididymal luminal protein of PDZ domain containing 1 is decreased in asthenozoospermia
A-Juan Liang, Gui-Shuan Wang, Ping Ping, Shuang-Gang Hu, Yu Lin, Yi Ma, Zheng-Zheng Duan, Han-Shu Wang, Fei Sun
March-April 2018, 20(2):154-159
DOI:10.4103/aja.aja_65_17  PMID:29405165
  3,513 569 1
Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia
Katherine Lang Rotker, Michael Alavian, Bethany Nelson, Grayson L Baird, Martin M Miner, Mark Sigman, Kathleen Hwang
March-April 2018, 20(2):195-199
DOI:10.4103/aja.aja_51_17  PMID:29205178
  3,398 442 4
Testosterone replacement therapy: Dilemmas and challenges in China and Asia
Qi An, Yi-Qun Gu
March-April 2018, 20(2):149-151
DOI:10.4103/aja.aja_16_17  PMID:29405166
  3,239 372 1
Fertility achieved through in vitro fertilization in a male patient with 48,XXYY syndrome
De-Feng Liu, Lian-Ming Zhao, Kai Hong, Jia-Ming Mao, Yu-Zhuo Yang, Zhe Zhang, Hui Jiang
March-April 2018, 20(2):208-209
DOI:10.4103/aja.aja_44_17  PMID:28980534
  3,226 335 1
Conclusions about testosterone therapy and cardiovascular risk
Bradley D Anawalt, Bu B Yeap
March-April 2018, 20(2):152-153
DOI:10.4103/aja.aja_7_18  PMID:29457599
  3,101 436 3
Globozoospermic infertility associated with balanced DPY19L2 translocation/gene deletion at the chromosomal breakpoint
Yan-Wei Sha, Li-Bin Mei, Liang-Kai Zheng, Rui-Hua Tian, Lu Ding, Zhi-Yong Ji, Qing Zhang, Ping Li
March-April 2018, 20(2):210-211
DOI:10.4103/1008-682X.196314  PMID:28272055
  3,154 325 1
Commentary on “Nondegloving technique for Peyronie's disease with penile prosthesis implantation and double dorsal-ventral patch graft”
Gerard D Henry, Kavina Jani
March-April 2018, 20(2):212-212
DOI:10.4103/aja.aja_53_17  PMID:29205179
  2,786 351 -